Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank83
Year-over-Year Change
Year-over-year free cash flow growth rate
Latest
-12.43%
↑ 72% vs avg
Percentile
P83
Within normal range
Streak
2 yr
Consecutive growthAccelerating
Average
-44.29%
Historical baseline
| Period | Value |
|---|---|
| 2024 | -12.43% |
| 2023 | -47.77% |
| 2022 | -49.11% |
| 2021 | -27.43% |
| 2020 | -64.11% |
| 2019 | -109.15% |
| 2018 | 0.00% |